On September 16, 2026, the FDA announced that Centric Compounding, a Texas-based compounding pharmacy, had recalled its compounded glutathione, Myers’ cocktail, and tri-immune boost injections nationwide after testing found elevated endotoxin levels in the products. It's the third such recall from a Texas compounding pharmacy in as many months, adding to a growing pattern of quality-control failures in the fast-growing market for compounded wellness injectables.

What Happened

The FDA said Centric Compounding had received nine reports of adverse events tied to its injectable products before issuing the recall. Endotoxins are components of the outer membrane of certain bacteria; even when a product looks clear and sterile, endotoxin contamination can survive standard sterilization steps like filtration if it isn't specifically screened for, and it doesn't require any live bacteria to remain in the final product to cause harm.

Why Endotoxin Contamination Is Dangerous

Injecting a product contaminated with bacterial endotoxin can trigger a strong inflammatory immune response. The FDA specifically warned that reactions can range from fever and chills to anaphylactic shock and death, particularly because the injection route bypasses the body's normal defenses against ingested toxins in a way an oral product would not.

Part of a Larger Pattern

This is the third glutathione-related recall tied to Texas compounding pharmacies since August 2026. The FDA has also linked two earlier recalls, from Victory Medical Center Pharmacy and Optimal Balance Pharmacy, to elevated endotoxin levels, and has noted that both of those facilities sourced supplement-grade glutathione from the same manufacturer. Across the three recalls, regulators have tallied at least 30 reported adverse events. Whether Centric Compounding used the same upstream glutathione supplier has not been confirmed publicly as of this writing.

Glutathione and Compounded Injectables: Where They Stand

Glutathione is not a research peptide in the sense of the compounds covered elsewhere on this site (it's a small tripeptide made of glutamate, cysteine, and glycine), but it's compounded and marketed through the same wellness-clinic and med-spa channels as many research peptides, often alongside NAD+, vitamin B12, or "Myers’ cocktail" IV blends. None of these formulations are FDA-approved drug products; they're prepared under a compounding pharmacy's state license, which means they don't undergo the same premarket testing, batch consistency requirements, or endotoxin screening as an FDA-approved sterile injectable.

What This Means for Patients

Sterile compounding for injectable products requires specialized cleanroom conditions and rigorous testing that isn't universal across the compounding industry. A product being "compounded" rather than counterfeit doesn't guarantee it was made under adequate sterility controls. Anyone who received glutathione, Myers’ cocktail, or tri-immune boost injections from Centric Compounding, or who develops fever, chills, or unusual reactions after any recent IV or injectable wellness treatment, should contact their prescriber or seek medical care rather than waiting to see if symptoms resolve.

The Bigger Regulatory Question

This recall lands in the middle of an active debate this site has tracked closely: how much oversight compounded peptides and compounded wellness injectables should receive as demand for both categories accelerates. Recalls like this one are likely to be cited by advocates of tighter compounding oversight, even as the FDA's own advisory panels have moved in the opposite direction this year on several individual peptides. Talk to a licensed physician or pharmacist before starting any compounded injectable therapy, and ask specifically about the compounding pharmacy's sterility testing and accreditation.